Infective Endocarditis: New Recommendations and Perspectives

  • Franck Thuny
  • Gilbert Habib


Infective endocarditis (IE) is a serious disease with an incidence ranging from 30 to 100 episodes/million patient-years (van der Meer et al. 1992a; Hogevik et al. 1995; Hoen et al. 2005). Mortality is high since more than one-third of patients will die within the first year of diagnosis (Cabell et al. 2002; Thuny et al. 2005). Prevention strategies have not lowered the incidence of this life-threatening disease (van der Meer et al. 1992a; Hogevik et al. 1995; Hoen et al. 2002; Berlin et al. 1995). Despite improvements in the diagnostic and therapeutic strategies, the fatality rate due to IE has not significantly decreased since the end of the 1970s. Important changes in the epidemiological profile of this disease that have occurred over the past few decades can explain a part of this situation. In fact, the age of patients and the incidence of health care-associated IE have increased as a consequence of the medical progress (Fowler et al. 2005; Benito et al. 2009; Sy and Kritharides 2010). Thus, the most frequent causative agents now tend to be aggressive pathogens such as staphylococci, resistant-enterococci, or fungi. Although significant geographical variations exist, a significant increase in the rate of staphylococcal IE has been reported in industrialized countries (Fig. 15.1) (Cabell et al. 2002; Fowler et al. 2005). Therefore, efforts should be made to develop new strategies at each step of IE management to reduce the residual causes of IE-related deaths. Challenges in IE management include (i) cost-effective measures of prevention, (ii) improvement of diagnostic strategies to reduce the delays for the initiation of the appropriate treatment, (iii) and better identification patients who require close monitoring and urgent surgery (Thuny et al. 2012).


Infective Endocarditis Antibiotic Prophylaxis Dental Procedure Coxiella Burnetii Good Oral Hygiene 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111:e394–434.PubMedCrossRefGoogle Scholar
  2. Benito N, Miro JM, de Lazzari E, et al. Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med. 2009;150:586–94.PubMedGoogle Scholar
  3. Berlin JA, Abrutyn E, Strom BL, et al. Incidence of infective endocarditis in the Delaware Valley, 1988–1990. Am J Cardiol. 1995;76:933–6.PubMedCrossRefGoogle Scholar
  4. Breitkopf C, Hammel D, Scheld HH, Peters G, Becker K. Impact of a molecular approach to improve the microbiological diagnosis of infective heart valve endocarditis. Circulation. 2005;111:1415–21.PubMedCrossRefGoogle Scholar
  5. Cabell CH, Jollis JG, Peterson GE, et al. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med. 2002;162:90–4.PubMedCrossRefGoogle Scholar
  6. Daly CG, Currie BJ, Jeyasingham MS, et al. A change of heart: the new infective endocarditis prophylaxis guidelines. Aust Dent J. 2008;53:196–200; quiz 97.PubMedCrossRefGoogle Scholar
  7. Duval X, Leport C. Prophylaxis of infective endocarditis: current tendencies, continuing controversies. Lancet Infect Dis. 2008;8:225–32.PubMedCrossRefGoogle Scholar
  8. Evangelista A, Gonzalez-Alujas MT. Echocardiography in infective endocarditis. Heart. 2004;90:614–7.PubMedCrossRefGoogle Scholar
  9. Fernandez-Hidalgo N, Almirante B, Tornos P, et al. Prognosis of left-sided infective endocarditis in patients transferred to a tertiary-care hospital-prospective analysis of referral bias and influence of inadequate antimicrobial treatment. Clin Microbiol Infect. 2010;17:769–75.CrossRefGoogle Scholar
  10. Forner L, Larsen T, Kilian M, Holmstrup P. Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation. J Clin Periodontol. 2006;33:401–7.PubMedCrossRefGoogle Scholar
  11. Fournier PE, Thuny F, Richet H, et al. Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis. 2010;51:131–40.PubMedCrossRefGoogle Scholar
  12. Fowler Jr VG, Miro JM, Hoen B, et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA. 2005;293:3012–21.PubMedCrossRefGoogle Scholar
  13. Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J. 2009;30:2369–413.PubMedCrossRefGoogle Scholar
  14. Habib G, Badano L, Tribouilloy C, et al. Recommendations for the practice of echocardiography in infective endocarditis. Eur J Echocardiogr. 2010;11:202–19.PubMedCrossRefGoogle Scholar
  15. Hall G, Hedstrom SA, Heimdahl A, Nord CE. Prophylactic administration of penicillins for endocarditis does not reduce the incidence of postextraction bacteremia. Clin Infect Dis. 1993;17:188–94.PubMedCrossRefGoogle Scholar
  16. Hoen B, Alla F, Selton-Suty C, et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA. 2002;288:75–81.PubMedCrossRefGoogle Scholar
  17. Hoen B, Chirouze C, Cabell CH, et al. Emergence of endocarditis due to group D streptococci: findings derived from the merged database of the International Collaboration on Endocarditis. Eur J Clin Microbiol Infect Dis. 2005;24:12–6.PubMedCrossRefGoogle Scholar
  18. Hogevik H, Olaison L, Andersson R, Lindberg J, Alestig K. Epidemiologic aspects of infective endocarditis in an urban population. A 5-year prospective study. Medicine (Baltimore). 1995;74:324–39.CrossRefGoogle Scholar
  19. Houpikian P, Raoult D. Blood culture-negative endocarditis in a reference center: etiologic diagnosis of 348 cases. Medicine (Baltimore). 2005;84:162–73.CrossRefGoogle Scholar
  20. Lacassin F, Hoen B, Leport C, et al. Procedures associated with infective endocarditis in adults. A case control study. Eur Heart J. 1995;16:1968–74.PubMedGoogle Scholar
  21. Lamas CC, Eykyn SJ. Blood culture negative endocarditis: analysis of 63 cases presenting over 25 years. Heart. 2003;89:258–62.PubMedCrossRefGoogle Scholar
  22. Lepidi H, Coulibaly B, Casalta JP, Raoult D. Autoimmunohistochemistry: a new method for the histologic diagnosis of infective endocarditis. J Infect Dis. 2006;193:1711–7.PubMedCrossRefGoogle Scholar
  23. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–8.PubMedCrossRefGoogle Scholar
  24. Lockhart PB. The risk for endocarditis in dental practice. Periodontol 2000. 2000;23:127–35.PubMedCrossRefGoogle Scholar
  25. Lockhart PB, Brennan MT, Sasser HC, Fox PC, Paster BJ, Bahrani-Mougeot FK. Bacteremia associated with toothbrushing and dental extraction. Circulation. 2008;117:3118–25.PubMedCrossRefGoogle Scholar
  26. Lodise TP, McKinnon PS, Swiderski L, Rybak MJ. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis. 2003;36:1418–23.PubMedCrossRefGoogle Scholar
  27. Millar BC, Moore JE. Current trends in the molecular diagnosis of infective endocarditis. Eur J Clin Microbiol Infect Dis. 2004;23:353–65.PubMedCrossRefGoogle Scholar
  28. Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169:463–73.PubMedCrossRefGoogle Scholar
  29. Raoult D, Casalta JP, Richet H, et al. Contribution of systematic serological testing in diagnosis of infective endocarditis. J Clin Microbiol. 2005;43:5238–42.PubMedCrossRefGoogle Scholar
  30. Richey R, Wray D, Stokes T. Prophylaxis against infective endocarditis: summary of NICE guidance. BMJ. 2008;336:770–1.PubMedCrossRefGoogle Scholar
  31. Strom BL, Abrutyn E, Berlin JA, et al. Dental and cardiac risk factors for infective endocarditis. A population-based, case-control study. Ann Intern Med. 1998;129:761–9.PubMedGoogle Scholar
  32. Sy RW, Kritharides L. Health care exposure and age in infective endocarditis: results of a contemporary ­population-based profile of 1536 patients in Australia. Eur Heart J. 2010;31:1890–7.PubMedCrossRefGoogle Scholar
  33. Thuny F, Di Salvo G, Belliard O, et al. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study. Circulation. 2005;112:69–75.PubMedCrossRefGoogle Scholar
  34. Thuny F, Grisoli D, Collart F, Habib G, Raoult D. Management of infective endocarditis: challenges and perspectives. Lancet. 2012;379:965–75.PubMedCrossRefGoogle Scholar
  35. van der Meer JT, Thompson J, Valkenburg HA, Michel MF. Epidemiology of bacterial endocarditis in the Netherlands. I. Patient characteristics. Arch Intern Med. 1992a;152:1863–8.PubMedCrossRefGoogle Scholar
  36. Van der Meer JT, Van Wijk W, Thompson J, Vandenbroucke JP, Valkenburg HA, Michel MF. Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis. Lancet. 1992b;339:135–9.PubMedCrossRefGoogle Scholar
  37. Westling K, Aufwerber E, Ekdahl C, et al. Swedish guidelines for diagnosis and treatment of infective endocarditis. Scand J Infect Dis. 2007;39:929–46.PubMedCrossRefGoogle Scholar
  38. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116:1736–54.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  • Franck Thuny
    • 1
  • Gilbert Habib
    • 1
  1. 1.Department of CardiologyLa Timone HospitalMarseilleFrance

Personalised recommendations